MoneyWorks4Me

Alivus Life Sciences informs about analyst meet

09 Jun 2025 Evaluate
Alivus Life Sciences has informed that pursuant to Regulation 30 and Para A of Part A of Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, details of the meetings with Investor/Analyst which will be held on June 12, 2025 and attended by the representatives of the Company is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1843.05
Dr. Reddys Labs. 1218.00
Cipla 1386.80
Lupin 2062.65
Zydus Lifesciences 1222.90
View more..